Silverarc Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-13,765	Closed	-$4.79M	–	90
2023 Q3	$4.79M	Buy	13,765 +590	+4%	+$206K	1.78%	31
2023 Q2	$4.64M	Sell	13,175 -6	-0%	-$2.02K	1.57%	25
2023 Q1	$4.15M	Buy	13,181 +1,797	+16%	+$539K	1.87%	25
2022 Q4	$3.29M	Buy	11,384 +279	+3%	+$85K	1.13%	39
2022 Q3	$3.21M	Buy	11,105 +691	+7%	+$199K	1.36%	30
2022 Q2	$2.94M	Buy	10,414 +2,776	+36%	+$743K	1.38%	32
2022 Q1	$1.99K	Buy	7,638 +2,638	+53%	+$626K	0.94%	30
2021 Q4	$1.1M	Buy	+5,000	New	+$972K	0.49%	59
2021 Q2	–	Sell	-7,500	Closed	-$1.61M	–	117
2021 Q1	$1.61M	Buy	7,500 +2,500	+50%	+$549K	0.9%	42
2020 Q4	$1.18M	Buy	+5,000	New	+$1.15M	0.72%	47